Chantelle Ankerman is an associate in Axinn’s Intellectual Property group. Her practice focuses on intellectual property litigation and counseling, particularly in the fields of pharmaceuticals, biotechnology, and medical devices. Chantelle has litigated Hatch-Waxman Paragraph IV patent infringement suits and Section 337 Investigations at the International Trade Commission, as well as complex antitrust and commercial litigation matters. Chantelle also has experience drafting and prosecuting U.S. and international patent applications in relation to an assortment of medical device, electrical, mechanical, and computer technologies.
Chantelle received her undergraduate degree in Physiology and Neurobiology from the University of Connecticut, and her law degree from the University of Connecticut School of Law, which she attended on a Dean’s Merit Scholarship. While at UConn Law, she served as a Symposium Editor for the Connecticut Law Review and earned CALI Awards for Excellence in Human Rights and Intellectual Property Law, and in Admiralty Law.
Professional Activities
- American Intellectual Property Law Association
- ChIPs (Chiefs in IP): Technology, Law, and Policy Women’s Affinity Group
- Connecticut Bar Association, Intellectual Property and Young Lawyers Sections
- American Bar Association, Intellectual Property Law Section
Experience
- Representing Norwich Pharmaceuticals Inc. in a patent infringement action filed by Salix Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Bausch Health Ireland Ltd., and Alfasigma S.P.A. The suit sought to stop Norwich from gaining approval to market a rifaximin 550 mg tablet, a generic of Salix’s Xifaxan®. Obtained judgment of invalidity on many of the asserted claims, which halted the trading of the plaintiff’s parent company’s stock after it plummeted following the decision. Axinn is currently handling the appeal in the Federal Circuit Court.
- Defended generic pharmaceutical company in Hatch-Waxman case concerning 18 patents and over 400 patent claims regarding Takeda’s (previously Shire’s) brand lisdexamphetamine capsules, Vyvanse®.
- Represented Alvogen in a patent infringement action filed by Novo Nordisk, Inc. and Novo Nordisk A/S. Alvogen sought to be among the first manufacturers to market a generic equivalent of Novo’s blockbuster brand semaglutide injection, Ozempic®, in the United States.
- Defense of Thales against the patent infringement action brought by Philips relating to 3G and 4G LTE wireless communication technology in an ITC investigation and obtained final determination of no violation on multiple grounds.
- Represented plaintiff in a breach of contract and fraud litigation involving a $20 million asset acquisition. The Court denied defendants’ motion for summary judgment on both the breach of contract and fraud claims, allowing the case to proceed to trial, while granting plaintiff’s motion for summary judgment dismissing the defendants’ counterclaims.
More
- Represented life sciences company in $12.5 billion merger.
- Represented generic pharmaceutical company in Hatch-Waxman patent infringement action involving an immunomodulator injection.
- Represented generic pharmaceutical company in Hatch-Waxman patent infringement action involving a boronic acid proteasome inhibitor.
- Represented pro bono client seeking assistance with website Terms of Use / Privacy Policy.
Honors
- ANDA Litigation Intelligence Report: Top 250 Best Performing ANDA Attorneys for Representing Defendants (2023)
- ANDA Litigation Intelligence Report: Top 250 Most Active ANDA Attorneys for Representing Defendants (2023)
University of Connecticut School of Law
- Dean’s Merit Scholarship
- CALI Awards for Excellence in Human Rights and Intellectual Property Law, Admiralty Law
Thought Leadership
- Key U.S. District Court Cases with Implications for IP in the New Year, IPWatchdog, December 15, 2023
- New Calif. Pay-For-Delay Law May Hurt Those It Aims to Help, Law360, November 5, 2019
- Failure to Launch: The Patent Thicket Delay of U.S. Biosimilars, Law360, October 9, 2019
Education
- JD – University of Connecticut School of Law (2017)
- BS, cum laude – University of Connecticut (2004)
Admissions
- Connecticut
- U.S. Patent and Trademark Office
- U.S. District Court District of Connecticut
- U.S. Court of Appeals for the Federal Circuit